Literature DB >> 31106128

A propensity score matching study of non-grasping en bloc mediastinal lymph node dissection versus traditional grasping mediastinal lymph node dissection for non-small cell lung cancer by video-assisted thoracic surgery.

Chenglin Guo1,2, Liang Xia1,2, Jiandong Mei1,2, Chengwu Liu1,2, Feng Lin1,2, Lin Ma1,2, Qiang Pu1,2, Lunxu Liu1,2.   

Abstract

BACKGROUND: The aim of our study was to compare the efficacy of lymph node (LN) dissection, short-term surgical outcomes, and long-term outcomes between non-grasping en bloc mediastinal lymph node dissection (NE-MLND) and traditional grasping mediastinal lymph node dissection (G-MLND) under video-assisted thoracic surgery (VATS) for non-small cell lung cancer (NSCLC).
METHODS: We retrospectively analyzed 872 patients with pathological stage I-III NSCLC who underwent VATS. The patient's demographic characteristics, short-term surgical outcomes, overall survival (OS) and disease-free survival (DFS) were assessed. A propensity score-matched (PSM) analysis was performed between NE-MLND and G-MLND to reduce bias, and 349 pairs of patients were matched.
RESULTS: Before propensity-score matching, for short-term surgical outcomes, the NE-MLND group had shorter operation time (P<0.001), more LNs removed (N1: P=0.002; N2: P<0.001; N1+N2: P<0.001), more pleural drainage during the first 3 days after surgery (P<0.001), and longer postoperative hospital stay (P<0.001). For long-term survival outcomes, the NE-MLND group had a longer OS (5-year OS: 71.8% vs. 64.8%, P=0.013), and there was no difference in DFS between the 2 groups (P=0.138). After propensity-score matching, the short-term surgical outcomes were consistent with the results before PSM. The OS and DFS in NE-MLND group were significantly longer than those in the G-MLND group (5-year OS: 76.4% vs. 63.5%, P=0.001 and 5-year DFS: 63.0% vs. 54.6%, P=0.033, respectively). Multivariate analysis showed that NE-MLND was an independent protective factor against OS [G-MLND: hazard ratio (HR) 1.461; 95% confidence interval (CI), 1.130-1.890; P=0.004].
CONCLUSIONS: NE-MLND is a safe, acceptable and superior approach to remove mediastinal LNs with shorter operation time. Patients with NSCLC may benefit from NE-MLND, which could lead to better OS and DFS as compared with G-MLND.

Entities:  

Keywords:  Non-grasping; en bloc; mediastinal lymph node dissection (MLND); non-small cell lung cancer (NSCLC); video-assisted thoracic surgery (VATS)

Year:  2019        PMID: 31106128      PMCID: PMC6504657          DOI: 10.21037/tlcr.2018.12.03

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN: 2218-6751


  23 in total

1.  Thoracoscopic mediastinal lymph node dissection for lung cancer.

Authors:  Atsushi Watanabe; Jyunnji Nakazawa; Masahiro Miyajima; Ryo Harada; Shinji Nakashima; Tohru Mawatari; Tetsuya Higami
Journal:  Semin Thorac Cardiovasc Surg       Date:  2012

2.  A new concept of endoscopic lung cancer resection: Single-direction thoracoscopic lobectomy.

Authors:  Lunxu Liu; Guowei Che; Qiang Pu; Lin Ma; Yigen Wu; Qiwei Kan; Xuepeng Zhuge; Lu Shi
Journal:  Surg Oncol       Date:  2009-06-04       Impact factor: 3.279

3.  Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?

Authors:  Christophe Doddoli; Adrian Aragon; Fabrice Barlesi; Bruno Chetaille; Stéphane Robitail; Roger Giudicelli; Pierre Fuentes; Pascal Thomas
Journal:  Eur J Cardiothorac Surg       Date:  2005-04       Impact factor: 4.191

4.  Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial.

Authors:  Jonathan D'Cunha; James E Herndon; Debra L Herzan; G Alexander Patterson; Leslie J Kohman; David H Harpole; Kemp H Kernstine; Jeffrey A Kern; Mark R Green; Michael A Maddaus; Robert A Kratzke
Journal:  Lung Cancer       Date:  2005-01-04       Impact factor: 5.705

5.  Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer.

Authors:  Michelle S Ludwig; Michael Goodman; Daniel L Miller; Peter A S Johnstone
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

6.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

7.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

8.  The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer.

Authors:  Valerie W Rusch; Hisao Asamura; Hirokazu Watanabe; Dorothy J Giroux; Ramon Rami-Porta; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2009-05       Impact factor: 15.609

9.  Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer.

Authors:  Ajeet Gajra; Nancy Newman; Gary P Gamble; Leslie J Kohman; Stephen L Graziano
Journal:  J Clin Oncol       Date:  2003-03-15       Impact factor: 44.544

10.  Long-term results of pathological stage I non-small cell lung cancer: validation of using the number of totally removed lymph nodes as a staging control.

Authors:  Yu-Chung Wu; Chien-Fu Jeff Lin; Wen-Hu Hsu; Biing-Shiun Huang; Min-Hsiung Huang; Liang-Shun Wang
Journal:  Eur J Cardiothorac Surg       Date:  2003-12       Impact factor: 4.191

View more
  3 in total

1.  Preoperative 3D-CT bronchography and angiography facilitates single-direction uniportal thoracoscopic anatomic lobectomy.

Authors:  Miao Zhang; Dong Liu; Wenbin Wu; Hui Zhang; Ning Mao
Journal:  Ann Transl Med       Date:  2019-10

2.  Long-term outcome in mediastinal malignancies: video-assisted thoracoscopic versus open surgery.

Authors:  Huynh Quang Khanh; Nguyen Van Khoi; Nguyen Lam Vuong
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-09-02

3.  Perioperative comparison of video-assisted thoracic surgery and open lobectomy for pT1-stage non-small cell lung cancer patients in China: a multi-center propensity score-matched analysis.

Authors:  Jinming Xu; Heng Ni; Yihe Wu; Jinlin Cao; Xingpeng Han; Lunxu Liu; Xiangning Fu; Yin Li; Xiaofei Li; Lin Xu; Yang Liu; Heng Zhao; Deruo Liu; Xin Peng; Jian Hu
Journal:  Transl Lung Cancer Res       Date:  2021-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.